Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
In a new study at Children’s Hospital of Los Angeles evaluating children with B-ALL, the most common type of cancer in children, researchers using Saphyr discovered an oncogenic variation that they...
-
SAN DIEGO, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and...
-
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that significant progress has been made in previously announced COVID-19 host genetics studies on...
-
SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced the publication of the first study to utilize its genome imaging system, Saphyr, for the analysis...
-
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that a study published in the journal Nature (Jebb, D., Huang, Z., Pippel, M. et al. Six...
-
Saphyr’s extremely sensitive structural variation detection technology will be used to analyze samples from COVID patients from dozens of clinical sites throughout North America and EuropeInitial...
-
Nature paper documents largest study of a single genetic disorder using Bionano genome imaging technology to date. Only Bionano’s Saphyr system was capable of resolving this extremely complex genome...
-
First large study in constitutional genetic diseases showed 100% concordance to all gold-standard cytogenetic testing methods combinedDemonstrates Bionano’s continued progress on goal of Saphyr...
-
SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that the first ever complete assembly of a human chromosome utilized its genome imaging technology...
-
SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), today announced that it has launched the new Bionano PrepTM SP Tissue and Tumor Kit, a DNA isolation kit developed...